You can use the form below and it will go into the general pool, or you can contact specific individuals:
For enquiries to the Board, please email ESGCT.
For everything related to the society including our membership, events, congresses and abstract submissions, please email Gaelle Jamar.
If your query relates to something contractual or financial, please email our accounts team.
If you're not quite sure where it fits, please email ESGCT and we will make sure it gets looked after!
The ESGCT has appointed WATS.ON to manage its administration, public engagement, and event organisation activities, you can send any post to ESGCT, c/o WATS.ON Ltd, 1 Abbey Street OX29 4TB UK
Non-viral genetic therapy strategies for the treatment of ataxia telangiectasia
James Grey received the ESGCT-sponsored prize for best poster presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about his winning presentation here!
Gene therapy for thrombotic thrombocytopaenic purpura
Robyn Bell received the ESGCT-sponsored prize for best oral presentation at the British Society for Gene and Cell Therapy (BSGCT) Annual Conference, which took place from 19-21 June 2019. Read about her winning presentation here!
CRISPR-Cas9 genome editing - molecular scissors a bit too sharp?
Grégoire Cullot received the ESGCT-sponsored prize for best oral presentation at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about his winning presentation here!
Dgkk as a new therapeutic target in the Fmr1-KO murine model of Fragile X
Karima Habbas received the ESGCT-sponsored prize for best poster at the Société Française de Thérapie Cellulaire et Génique (SFTCG) Thematic Day on Viral Vectors, which took place on 17 May 2019 in Paris. Read about her winning presentation here!